Rigel Pharmaceuticals | RIGL - Credores Comerciais





Credores Comerciais Alterar Data
Agenus USD 58.98M 12.1M 2026-06
Amgen USD 20.83B 17.97B 2026-09
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 23.57B 679M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Celldex Therapeutics USD 11.24M 3.44M 2026-09
Daiichi Sankyo JPY 612.24B 73.19B 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
Heron Therapeutics USD 8.38M 3.27M 2026-09
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 4.1M 5.31M 2026-09
MacroGenics USD 3.44M 845K 2026-06
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Pfizer USD 4.07B 511M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
Veracyte USD 9.71M 1.69M 2026-09